Medical-Surgical Nursing · Musculoskeletal System

Muscular Dystrophy

10 min read

On this page 9 sections

In 30 seconds
Why this matters
The college version
Eli explains
Worked example
Key takeaway
Check yourself
Study tools
Sources & references

In 30 seconds

(MD) is not one disease but a family of inherited genetic disorders that cause progressive degeneration and weakness of skeletal muscle. In every form, muscle fibers gradually die and are replaced by fat and fibrous scar tissue, so muscles weaken over time even as some may appear bulky. What differs between forms is the specific gene defect, pattern of inheritance, age of onset, which muscles are affected first, and how fast the disease progresses.

The most important forms to know are Duchenne muscular dystrophy (DMD) and its milder cousin Becker muscular dystrophy (BMD), both caused by defects in the gene for , a protein that keeps muscle fibers from tearing when they contract. Myotonic dystrophy, facioscapulohumeral dystrophy, and limb-girdle dystrophies are other family members. Because the disorders are genetic, they affect people across the lifespan — from young children with DMD to adults with myotonic dystrophy.

Why this matters

Muscular dystrophy is a chronic, progressive, incurable condition, and nursing care is central to quality of life across the illness trajectory:

It affects more than muscles. Respiratory muscle weakness, cardiac involvement, and swallowing problems are common in the dystrophies and are the usual causes of serious complications — so nursing surveillance of breathing, heart, and nutrition is life-sustaining.
Mobility and safety are nursing domains. Progressive weakness means rising fall risk, pressure injury risk, and the need for assistive devices, transfers, and skin care.
It is a family disease. Because the conditions are inherited, nurses support genetic counseling, family education, and sometimes grief and anticipatory loss. Person-first language is a professional and ethical baseline.
Multidisciplinary teamwork is the model. Neurologists, cardiologists, pulmonologists, physical and occupational therapists, dietitians, and nurses work together; the nurse is often the coordinator and the constant presence for the family.

The college version

Core Concepts

The muscle problem: dystrophin

Skeletal muscle fibers are packed with proteins that let them contract and that anchor the fiber to its surrounding membrane. Dystrophin is a giant structural protein that links the internal machinery of the muscle fiber to the membrane, acting like a shock absorber during contraction. In Duchenne muscular dystrophy, a mutation in the dystrophin gene (on the X chromosome) means the body makes little or no functional dystrophin; in Becker muscular dystrophy, the same gene produces a shortened, partially functional dystrophin. Without enough working dystrophin, muscle fibers tear themselves apart with every contraction, die, and are replaced by fat and connective tissue — which is why calves may look unusually large () in a person who is actually weak: the bulk is fat and scar, not muscle.

Inheritance patterns

Duchenne and Becker MD: . The gene sits on the X chromosome, so the condition overwhelmingly affects males; females are usually carriers (though carriers can have mild symptoms or, rarely, significant disease). A carrier mother has a 50% chance of passing the affected X to each child; affected males do not pass the gene to sons (sons get the Y from father) but all daughters become carriers. Male-to-male transmission does not occur — a classic exam point.
Myotonic dystrophy: autosomal dominant. One copy of the abnormal gene is enough, so each child of an affected parent has a 50% chance of inheriting it; males and females are affected equally. It involves a repeated DNA segment that tends to expand in successive generations — a phenomenon called , meaning the disease often appears earlier and more severely in children than in the affected parent.
Facioscapulohumeral (FSHD) and limb-girdle dystrophies also follow dominant or recessive patterns depending on the specific form; genetic testing clarifies each family's situation.

Duchenne muscular dystrophy — the prototype

Onset: symptoms typically appear between ages 2 and 5 — delayed motor milestones, a waddling gait, trouble running and climbing stairs, and frequent falls.
The : to rise from the floor, the child "climbs up" their own legs with their hands because hip and thigh muscles are too weak — a classic physical finding.
Pattern of weakness: proximal muscles (hips, shoulders, trunk) are affected before distal muscles; calf pseudohypertrophy is common.
Course: weakness progresses steadily; most children lose the ability to walk by early adolescence. Cardiomyopathy (heart muscle weakening) and respiratory muscle weakness are the major long-term threats and the focus of surveillance. Some children have learning or behavioral differences as well.
Diagnosis: elevated serum creatine kinase early on, genetic testing to confirm the mutation, and sometimes muscle biopsy or electromyography. (Diagnosis is a provider decision; the nurse's role is preparation and support.)

Becker muscular dystrophy

BMD is the same gene but a milder defect: onset is later (often adolescence or adulthood), progression is slower, and people usually remain ambulatory much longer. Cardiac involvement can still be significant even when skeletal muscle weakness is mild — a reminder to never judge heart risk by limb strength.

Myotonic dystrophy — a different flavor

Here the hallmark is : muscles contract but relax slowly, so a person may have trouble letting go of a handshake or releasing a grip. Weakness tends to start distally (hands, feet) and in facial muscles (a "hatchet face" appearance, ptosis). Beyond muscle, myotonic dystrophy commonly involves cardiac conduction abnormalities, cataracts, and endocrine changes, and it shows anticipation across generations.

Diagnosis and management overview

Diagnosis combines clinical history and exam with genetic testing; serum creatine kinase is often elevated (dramatically so in DMD) and muscle biopsy/EMG may be used when genetics are inconclusive. There is no cure, and no treatment reverses the muscle loss. Management is supportive, proactive, and multidisciplinary:

Physical and occupational therapy — stretching, positioning, splinting, and assistive devices to delay contractures and preserve function.
Respiratory care — monitoring cough strength and sleep, secretion clearance techniques, and noninvasive ventilation as prescribed when breathing weakens.
Cardiac surveillance — regular cardiology follow-up as recommended by the specialist team.
Nutrition and swallowing — monitoring for chewing/swallowing difficulty and aspiration risk; dietitian involvement.
Mobility and skin — wheelchairs, transfers, pressure injury prevention.
Medications — for example, corticosteroids are sometimes prescribed by specialists in DMD to slow progression; they have significant side effects, so teaching and monitoring are essential. Other medications target symptoms and complications — all prescribed and managed by the provider team.
Genetic counseling and family support — helping families understand inheritance, testing options, and available resources; advance care planning conversations when appropriate, respecting the person's and family's values.

Nursing care priorities

Person-first, relationship-based care: the person and family are the experts on their own lives; the nurse partners with them.
Respiratory surveillance: watch for weaker cough, increased work of breathing, frequent respiratory infections, and sleepiness — and escalate promptly. Respiratory infection is a serious event for a person with weak respiratory muscles.
Cardiac awareness: know that cardiomyopathy is a risk in DMD/BMD and report palpitations, fatigue, or dyspnea.
Safe mobility and transfers: falls and fractures are real risks; use lifts and transfer techniques per protocol.
Skin integrity: pressure injury prevention with positioning and specialized surfaces.
Nutrition and swallowing: observe meals, note coughing or choking, and involve speech therapy as indicated.
Education and advocacy: teach the family about the disease, warning signs, medication side effects, and available support organizations; refer to genetic counseling and palliative/supportive services as appropriate.

All diagnostic testing, medication, and treatment decisions are made by the provider; the nurse monitors, teaches, coordinates, and supports. Scope of practice and institutional resources vary.

Common Confusions

Do not confuse	With	Difference
Muscular dystrophy	Multiple sclerosis (MS)	MD is an inherited muscle disease; MS is an autoimmune nerve/myelin disease of the CNS with relapses and remissions
Muscular dystrophy	Myasthenia gravis	MD = progressive genetic degeneration of muscle; MG = autoimmune attack on the nerve–muscle junction causing fatigable weakness that improves with rest
Duchenne MD	Becker MD	Same gene, different severity: DMD = absent dystrophin, early onset, faster progression; BMD = partial dystrophin, later onset, slower
Pseudohypertrophic calf	A strong, well-muscled calf	The bulk is fat/scar tissue replacing muscle — the person is weak, not strong
Gowers sign	General difficulty standing	The specific hand-on-thigh "climbing" maneuver points to proximal muscle weakness (classically DMD)
X-linked recessive transmission	Autosomal dominant transmission	X-linked: mostly males affected, carrier mothers, no male-to-male passage; autosomal dominant: males and females affected, 50% risk per child

Eli explains

The same idea, in plain words

Explain it like I’m 10

Your muscles are like rubber bands that squeeze to move you, and they need a special "glue" protein called dystrophin so they don't tear when they squeeze. Some people inherit a body that can't make this glue properly, so their muscles slowly get weaker and are replaced by fat. It runs in families, and while there is no cure, therapy, breathing and heart check-ups, and good care help people stay strong, comfortable, and independent for as long as possible.

Worked example

The clinic visit. Marcus, 6, is at the neuromuscular clinic with his mother. The nurse reviews his history: he was late to walk, waddles, falls often, and struggles to get up from the floor — the nurse observes him use his hands to push up his own legs (Gowers sign) and notes prominent calves that feel firm but are clearly weak (pseudohypertrophy). The care team is pursuing genetic testing for Duchenne muscular dystrophy; the nurse's role today is to prepare Marcus and his mother for the visit, answer questions in plain language, and begin teaching: what the diagnosis may mean, why respiratory and cardiac follow-up will matter, what physical and occupational therapy can do, and how to connect with support resources. The nurse also listens: Marcus's mother worries about her other children, so the nurse explains that genetic counseling will help the family understand inheritance and testing options. The nurse uses person-first language throughout: Marcus is a child who has muscular dystrophy, not "a dystrophy patient."

The teaching point: even before the diagnosis is confirmed, the nurse's job is assessment, education, support, and coordination — not diagnosis or treatment decisions, which belong to the provider team.

Key takeaways

MD is a family of inherited, progressive muscle diseases — the problem is in the muscle itself, not the nerve.
DMD and BMD are X-linked recessive, caused by dystrophin gene defects: DMD = little/no dystrophin, early onset, severe; BMD = partial dystrophin, later onset, milder. No male-to-male transmission.
Gowers sign (climbing up the legs to stand) and calf pseudohypertrophy are classic DMD findings; proximal weakness comes before distal.
Myotonic dystrophy is autosomal dominant with anticipation (earlier, worse disease in later generations) and features myotonia — slow muscle relaxation.
The life-threatening systems are respiratory and cardiac — surveillance of breathing, cough, sleep, and heart is a nursing priority.
Serum creatine kinase is often elevated early in DMD (conceptually — no memorized ranges needed); genetic testing confirms the diagnosis.
No cure — care is multidisciplinary, supportive, and lifelong; corticosteroids in DMD are a specialist-prescribed option with serious side effects requiring teaching.
Person-first language and family/genetic-counseling support are standard of care.

Check yourself

5 review questions from the chapter. Try each one, then open the answer.

What is the difference between Duchenne and Becker muscular dystrophy at the protein level, and how does that explain their different courses?
Show answer
In DMD the dystrophin gene produces little or no functional dystrophin, so muscle fibers tear and die from early childhood — severe, rapid course. In BMD the gene produces a shortened, partially functional dystrophin, so onset is later and progression slower.
Why does male-to-male transmission of DMD/BMD not occur?
Show answer
Because the dystrophin gene is on the X chromosome: a male passes his Y chromosome to sons, so affected males never pass the defective X to sons (all daughters become carriers).
What is the Gowers sign, and what does it indicate?
Show answer
Gowers sign is the child using their hands to "climb up" their own legs to stand; it indicates proximal hip/thigh weakness, classically seen in DMD.
Why might a child with DMD have large-looking calves but weak legs?
Show answer
Pseudohypertrophy — the calf bulk is fat and fibrous tissue replacing degenerated muscle, so the leg looks big but is weak.
Name three nursing surveillance priorities for a person with DMD as the disease progresses.
Show answer
Examples: respiratory surveillance (cough strength, work of breathing, sleep, infections), cardiac surveillance (signs of cardiomyopathy), safe mobility/transfers and fall prevention, skin integrity/pressure injury prevention, and nutrition/swallowing with aspiration risk.

Keep learning

Ready to build on this? Continue to the next lesson.

Study tools & related lessonsKey vocabulary · Related

Key vocabulary

Muscular dystrophy: A family of inherited diseases causing progressive muscle fiber degeneration and weakness
Dystrophin: A structural protein that stabilizes muscle fibers during contraction
Gowers sign: Using the hands to "climb up" the legs when rising from the floor
Pseudohypertrophy: Enlarged-looking muscle (e.g., calf) that is actually fat and scar tissue
Myotonia: Slow relaxation of muscle after contraction
X-linked recessive: Inheritance pattern where the gene is on the X chromosome
Anticipation: A genetic condition that appears earlier and more severely in later generations

Sources & references

openstax.org — Medical Surgical Nursing

This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.

Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.